Purpose Autologous hematopoietic cell transplantation (HCT) is being increasingly used as
an effective treatment strategy for patients with relapsed or refractory Hodgkin's lymphoma (…

… Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of
activities and trends over 30 years. Bone Marrow Transplant. 2021;56:1651–64. …

Hyposalivation is a common adverse effect of anti-neoplastic therapy of head and neck
cancer, causing impaired quality of life and predisposition to oral infections. However, data on …

… hematopoietic cell transplantation (HCT) results in large part from the development of acute
graft-versus-host disease (GVHD), we previously proposed that a longitudinal assessment of …

Although generally not applied as first-line treatment of multiple myeloma, allogeneic
hematopoietic cell transplantation (allo-SCT) can still be chosen as ultimate escalation approach in …

… ) and QoL assessment at regular and frequent intervals throughout treatment and then
comparing them to established approaches of cellular therapy (ie, stem cell transplantation [SCT]) …

… In this setting, the novelty of our data stands in the longitudinal assessment of clinical (TV)
and biochemical parameters of testicular function over time, that led us to highlight a …

… large-scale, prospective, longitudinal assessments of the relationship … cell transplantation
candidates before transplantation that were much less pronounced 1 year after transplantation. …

… We studied longitudinally B-cell development and function in a cohort of 13 PID patients
transplanted between 1997 and 2010, with a follow-up ranging from 0.7 to 15 years. Flow …

Pediatric donors may be at increased risk of psychological and social challenges following
hematopoietic cell transplantation (HCT). Through a retrospective chart review, we evaluated …